Press Releases
 
Human Albumin and Factor Vlll (FVIII) Market

Transparency Market Research Report Added "Human Albumin and Factor Vlll (FVIII) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2023"

United States, 20 March 2017 -- Human Albumin and Factor Vlll (FVIII) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2023

Human albumin is a type of protein, commonly found in human blood plasma. Human albumin is normally synthesized in liver. Factor Vlll is a blood clotting protein and also known as anti-hemophilic factor (AHF). Defect in production of Factor Vlll may result in hemophilia A (genetic deficiency in clotting factor). This protein circulates in bloodstream in an inactive form. In response to the injury, factor Vlll initiates the chemical reaction that forms a blood clot. Factor Vlll are also extracted from the human plasma or engineered from mammalian cell culture by means of recombinant DNA technology and can be used to treat patients with hemophilia disease. 

Rising incidences of hemophilia will drive the growth of the market of human albumin and factor VIII market. According to National Hemophilia Foundation, approximately one in 5,000 male in the U.S. are affected with hemophilia. In addition, strategic collaboration by key players in order to introduce novel treatment options will further drive the market growth. For example, Novo Nordisk collaborated with National Hemophilia Foundation aiming to develop novel treatment option for hemophilia disease. Thus, these types of collaboration will build healthy platform to attract new customers and hence drive the market growth. 

Furthermore, rising geriatric population will significantly drive the market growth of human albumin and factor VIII market. According to a report published by World Health Organization (WHO), the number of people aged 65 years and above is expected to increase from 605 million to 2 billion by 2050. Additionally, advances in factor VIII product resulted in a major increase in quality of life of patients and hence supports the growth of human albumin and factor VIII. Moreover, various other factors like rising number of people with bleeding disorders, rising use of albumin as cell culture medium ingredient and low cost therapy will further augment the growth of the market. However, stringent regulation and lack of adequate plasma supplies will restrain the growth of human albumin and factor VIII market. 

In addition, high cost of therapies coupled with lack of adequate treatment modalities in developing countries like Asia-Pacific will restrain the growth of this market. For example, advanced therapeutics for the treatment are only available in the developed countries like North America and Europe.

For more information on this report, fill the form @http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10238

Geographically, North America dominates the global human albumin and factor VIII market. Increasing use of plasma derived products in North America will drive the growth of human albumin and factor VIII market in North America. Europe is considered as the second largest market of human albumin and factor VIII market. The growth of the market in Europe is majorly driven by aging population. Rise in geriatric population will increase the risk of the people diagnosed with hemophilia which drives the growth of human albumin and factor VIII market in European market. 

According to Eurostat (European Commission) report published in 2013, around 17.8% of the European population were aged 65 years and above. The market of human albumin and factor VIII market in Asia-Pacific holds a strong growth as there is a rise in total number of bleeding disorder cases in this region. In addition, emerging countries like India and China are increasingly importing albumins from western countries (i.e. North America and Europe) which will ultimately drive the overall growth of this market in Asia-Pacific region. 

Some of the key players dominating the global human albumin and factor VIII market comprises Baxter International, Inc., Talecris Plasma Resources, Grifols, S.A., Novo Nordisk, CSL Limited and others.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

# # #


About :
M140o93H7pQ09L8X1t49cHY01Z5j4TT91fGfr

Media Contacts:
Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
//

Footnotes:
5186181030

Note To Editors:
Albany,

Disclaimer:
Albany,


Image Attached Image Attached Download file at: New York
(Right click and save file to download.)

Document Attached Image Attached Download file at: 12207
(Right click and save file to download.)

Submitted by Sandy Researcher, Transparency Market Research on Monday, 20 March 2017 at 8:31 PM
Category: Health Care & Medical
 
Related News

Nutritional supplements or flu shots Charlottesville available near home
Sunday, 23 Jul 2017

Depend on local drug stores for specific vaccines
Sunday, 23 Jul 2017

Meadowbrook Pharmacy continuing to serve the locality
Sunday, 23 Jul 2017

Why is compounding pharmacy Charlottesville so important?
Sunday, 23 Jul 2017

Services offered by local Pharmacy Charlottesville
Sunday, 23 Jul 2017

Related Events

AHRMM17 - The Leading Healthcare Supply Chain Conference and Exhibition
Sunday, 23 Jul 2017

Success With Failure: Strategies for the Evaluation and Treatment of Heart
Monday, 24 Jul 2017

Echocardiographic Symposium at Vail
Monday, 24 Jul 2017

5th Digital Pharma China
Monday, 24 Jul 2017

Microfluidics Congress USA
Monday, 24 Jul 2017

Latest News

Smartphones - Which A single Need to I Acquire?
Sunday, 23 Jul 2017

Nutritional supplements or flu shots Charlottesville available near home
Sunday, 23 Jul 2017

Depend on local drug stores for specific vaccines
Sunday, 23 Jul 2017

Meadowbrook Pharmacy continuing to serve the locality
Sunday, 23 Jul 2017

Why is compounding pharmacy Charlottesville so important?
Sunday, 23 Jul 2017

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2017
Today is Sunday, 23 July 2017

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Trendy Juniors Clothes - Treats For your Children
  • Need for Corporate Gifts
  • AHRMM17 - The Leading Healthcare Supply Chain Conference and Exhibition
  • Force Vive - Une semaine pour deployer ses ailes (23 au 29 juillet 2017)
  • Success With Failure: Strategies for the Evaluation and Treatment of Heart

  • Latest Jobs
  • Gold Ore Milling Machine Advantages
  • London Investment Property
  • We Are Hiring A Content Manager!